Evidence map›Paper›PMID 25333865›Full record

ArticleImmunology2015

Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.

Gayatri Mukherjee, Rodolfo J Chaparro, Jennifer Schloss, Carla Smith, Christopher D Bando, Teresa P DiLorenzo

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gayatri MukherjeeDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Rodolfo J Chaparro
Jennifer Schloss
Carla Smith
Christopher D Bando
Teresa P DiLorenzo
Albert Einstein College of Medicine · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Antigens Recognized by CD8+ T Cells in Type 1 DiabetesR01DK064315 · NIDDK · YESHIVA UNIVERSITY · PI DILORENZO, TERESA P · 2003 to 2015
$3.8M
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic CellsR01DK094327 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DILORENZO, TERESA P · 2011 to 2015
$1.8M
NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P60 DK020541NIDDK NIH HHS R01 DK064315NIDDK NIH HHS R01 DK094327NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

Type 1 diabetes is characterized by T-cell-mediated destruction of the insulin-producing β cells in pancreatic islets. A number of islet antigens recognized by CD8 T cells that contribute to disease pathogenesis in non-obese diabetic (NOD) mice have been identified; however, the antigenic specificities of the majority of the islet-infiltrating cells have yet to be determined. The primary goal of the current study was to identify candidate antigens based on the level and specificity of expression of their genes in mouse islets and in the mouse β cell line MIN6. Peptides derived from the candidates were selected based on their predicted ability to bind H-2K(d) and were examined for recognition by islet-infiltrating T cells from NOD mice. Several proteins, including those encoded by Abcc8, Atp2a2, Pcsk2, Peg3 and Scg2, were validated as antigens in this way. Interestingly, islet-infiltrating T cells were also found to recognize peptides derived from proglucagon, whose expression in pancreatic islets is associated with α cells, which are not usually implicated in type 1 diabetes pathogenesis. However, type 1 diabetes patients have been reported to have serum autoantibodies to glucagon, and NOD mouse studies have shown a decrease in α cell mass during disease pathogenesis. Our finding of islet-infiltrating glucagon-specific T cells is consistent with these reports and suggests the possibility of α cell involvement in development and progression of disease.

Indexed as

AnimalsAutoantigensAutoimmunityCD8-Positive T-LymphocytesCell Line, TumorComputational BiologyDiabetes Mellitus, Type 1Disease Models, AnimalEnzyme-Linked Immunospot AssayEpitope MappingEpitopes, T-LymphocyteH-2 AntigensInterferon-gammaInterferon-gamma Release TestsIslets of LangerhansMice, Inbred NODAutoantigensEpitopes, T-LymphocyteH-2 AntigensH-2K(K) antigenInterferon-gammaProglucagonautoantigensglucagonNOD micetype 1 diabetes

Identifiers

PMID25333865
PMCPMC4368169
OpenAlexW2103714652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.